Clinical Trial Update: Bioequivalence Study in Healthy Subjects [Phase 1]

View source ↗

Summary

A Phase 1 bioequivalence study in healthy subjects sponsored by AstraZeneca for hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Snippet

Sponsor: AstraZeneca | Conditions: Hypertension | Phase 1 | Status: COMPLETED